All News

Stem Cells

Cell Therapy to Restore Function in Heart Failure Dosed to First Patient, Novo Nordisk and Heartseed Announce
15 February 2023
Cell Therapy to Restore Function in Heart Failure Dosed to First Patient, Novo Nordisk and Heartseed Announce
Heartseed Inc (Tokyo, Japan) and
Genome Editing Tools and Techniques for Cancer Therapies
3 January 2023
Genome Editing Tools and Techniques for Cancer Therapies
For this interview, Phacilitate’s Ryan
Avectas, CCRM and OmniaBio’s Collaboration to Accelerate the Manufacture of Edited iPSCs
30 November 2022
Avectas, CCRM and OmniaBio’s Collaboration to Accelerate the Manufacture of Edited iPSCs
Irish based cell engineering technology
FDA Gives Go-Ahead for New Gene Therapy Clinical Trial in Cystic Fibrosis
2 August 2022
FDA Gives Go-Ahead for New Gene Therapy Clinical Trial in Cystic Fibrosis
Pivotal-stage gene therapy company Krystal
POPULAR NEWS ITEMS
Image
23 March 2023

Gilead’s Yescarta Demonstrates Improvement in Overall Survival for Aggressive Blood Cancers

Image
14 March 2023

Pfizer Invests $43 Billion to Acquire Seagen

Image
2 March 2023

Early Adoption and Partnerships – The Secret to Commercialization Success?

First Patient Successfully Treated by Ex Vivo Lentiviral Gene Therapy for RAG1-SCID
1 August 2022
First Patient Successfully Treated by Ex Vivo Lentiviral Gene Therapy for RAG1-SCID
Mustang Bio has announced that
Phacilitate Announces the Inauguration of First Gala Awards Dinner to Celebrate the Achievements of the Advanced Therapies Field
27 June 2022
Phacilitate Announces the Inauguration of First Gala Awards Dinner to Celebrate the Achievements of the Advanced Therapies Field
Phacilitate answers industry’s call for
Two bluebird bio Gene Therapies Achieve Unanimous FDA Support
16 June 2022
Two bluebird bio Gene Therapies Achieve Unanimous FDA Support
Bluebird bio celebrates a big
Advanced Therapies Week Content Library
12 May 2022
Advanced Therapies Week Content Library
Following Advanced Therapies Week 2022,
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

Gilead’s Yescarta Demonstrates Improvement in Overall Survival for Aggressive Blood Cancers

Image

Pfizer Invests $43 Billion to Acquire Seagen

Image

Early Adoption and Partnerships – The Secret to Commercialization Success?